3 completed, 1 withdrawn. 2 Phase 1, 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Carbon-11: new trials by email Literature Review of Carbon-11 trials Research Report on Carbon-11
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression Sodium Acetate C11 PET/CT Imaging - Gliomas | Phase 2 / Phase 3 | Withdrawn | Phoenix Molecular Imaging | 2014-05-01 | 2016-09-28 | |
| C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma C11-Sodium Acetate - Prostate Cancer, Prostate Adenocarcinoma | Phase 2 | Completed | Phoenix Molecular Imaging | 300 | 2012-04-01 | 2019-03-07 |
| Imaging of Cannabinoid Receptors Using New Radioactive Tracer [(11)C] MePPEP - Healthy | Phase 1 | Completed | National Institute of Mental Health (NIMH) | 25 | 2007-03-19 | 2017-07-02 |
| PET Imaging of Brain Peripheral Benzodiazepine Receptors [(11)C] PBR28 - Healthy Volunteer | Phase 1 | Completed | National Institute of Mental Health (NIMH) | 25 | 2006-01-26 | 2017-07-02 |
Glioblastoma (1) · Glioma (1) · Prostatic Neoplasms (1) · Recurrence (1)
National Institute of Mental Health (NIMH) (2) · Phoenix Molecular Imaging (2)
United States (4)